Open Access

A retrospective analysis of dengue fever case management and frequency of co-morbidities associated with deaths

  • Muhammad Arif Nadeem Saqib1Email author,
  • Ibrar Rafique1,
  • Saira Bashir2 and
  • Arsalan Ahmad Salam3
BMC Research Notes20147:205

https://doi.org/10.1186/1756-0500-7-205

Received: 26 July 2013

Accepted: 28 March 2014

Published: 1 April 2014

Abstract

Background

Dengue epidemic in Lahore (2011) resulted in hundreds of deaths and affected thousands. As most of the studies were focused on its diagnosis and treatment, scanty data is available on associated diseases/co-morbidities in these patients that could have contributed to a higher mortality. There were no local guidelines available on recording, reporting and management of these co-morbidities. The objective of this study was to analyze the initial presentations of dengue cases and to estimate the frequency of co-morbidities in dengue patients.

Methods

Data of 556 dengue cases was retrieved from 2 major public sector tertiary-care hospitals for patients who were admitted during 2011 epidemic and a case record analysis was done. Data was retrieved from patient’s information reports which included demography, signs and symptoms and the laboratory investigations. In addition verbal autopsy of deceased cases was also done from their relatives using standardized WHO verbal autopsy form after making modifications as per needed.

Results

Of 556 cases studied, 390 (70%) were males. The mean age was 36 years and 30% of the cases were between 20-29 years. Average duration of the hospital stay was 6 days. Out of the total, 435 (78%) were dengue fever (DF) cases followed by dengue hemorrhagic fever (DHF) in 95 (17%) and dengue shock syndrome (DSS) in 26 (4%) cases. A total of 40 cases died and among them 17 were diagnosed with DSS, 13 DF and 10 DHF. Further the verbal autopsy from relatives of deceased cases showed 29 (60%) deceased had co-morbid diseases which included hypertension, diabetes etc. DSS was common in patients who had hypertension (27) either alone or associated with other illnesses.

Conclusions

Co-morbidities with dengue infection were seen in 60% deceased cases indicating the reasons for high dengue related complications and death.

Keywords

Dengue Co-morbid Hypertension

Background

Dengue fever emerged from Africa almost 500-600 years ago and reached Asia in 1780’s [1]. In recent decades, it has become the second most prevalent mosquito (Aedes aegypti) borne infection after malaria [2]. Dengue has affected almost 120 countries with high incidence in many [3] putting half of the world’s population at risk [4]. According to WHO estimates, currently there are 50-100 million dengue cases around the world [5]. Dengue virus can lead to a spectrum of diseases ranging from sub-clinical infection to dengue fever and most severe forms like dengue hemorrhagic fever and dengue shock syndrome [6].

Co-morbidities in dengue patients result in complications leading to deaths. A study from Singapore reported that out of every 27 deaths due to dengue, 21 had co-morbidities [7]. Another study reported that dengue patients with allergies or diabetes are 2.5 times more at risk of developing dengue hemorrhagic fever [8]. Likewise higher frequency of complications is reported in dengue patients suffering from hepatitis [911].

Verbal autopsy is an indirect method of determining cause of death based on interviews with the care takers of deceased individuals and has been widely used to collect information on cause specific mortality [12]. In addition to gathering information on cause of death, verbal autopsy is also important for investigating outbreaks due to infectious diseases [13]. Many countries use verbal autopsy methods on large scale to assess cause of death in a population [14, 15]. The present study was proposed to analyze the initial symptoms of dengue fever and to determine the frequency of co-morbidities in deceased cases.

Methods

This was a retrospective, cross-sectional study and was conducted in the community of Lahore and hospital records of two tertiary care hospitals i.e. King Edward Medical University, Lahore (Mayo Hospital) and Fatima Jinnah Medical College, Lahore (Ganga Ram Hospital). Complete medical record of all dengue cases which included signs and symptoms, method of diagnosis, management, duration of stay and clinical outcome was retrieved from patient’s information reports. The diagnosis of patients into DF, DHF and DSS was taken from their case record and analyzed accordingly.

The relatives of deceased were interviewed using WHO verbal autopsy guidelines (Additional file 1). Verbal autopsy questionnaire were pre-tested by interviewing attendants of fewer cases and modified as per needs. All interviews were done by trained interviewers in local language i.e. Urdu. A written informed consent was taken from relative of deceased who were attendants of patient during the hospital stay (father, brother, sister or others). Demographic, epidemiological, co-morbidity and other details were obtained from the relatives. A sample size of 60 deceased was calculated for Lahore, however verbal autopsy of 48 deceased cases was done (40 were those whom addresses were retrieved from the records of the selected 02 hospitals while 08 were included during field interviews). These 08 cases were admitted in any other hospitals of Lahore and died. The ethical clearance was taken from Institutional ethic committee of Pakistan Medical Research Council.

Statistical analysis

Data collected was double entered in, cleared and coded using Excel sheet (Window 2007) and analysis was done using SPSS 16.0. Chi-square test was used to compare the categorical variables and p ≤ 0.05 was considered statistically significant.

Results

Of the total 556 cases, 390 (70%) were males and 166 (30%) females with a mean age of 36 years and majority in 20-29 years age group. Average duration of hospital stay was 6 days. The data showed that 435(78%) cases had DF, 95 (17%) had DHF and 26 (4%) DSS. Majority (64%) was positive for both IgG and IgM and pattern of positivity in DF, DHF and DSS is given in Table 1. Five day record of symptoms showed that all patients had a high grade fever (103°F) at the time of admission which settled or subsided by 5th day of admission. Fever, bleeding, headache, vomiting, abdominal pain, rash and shock were common symptoms on admission. However, bleeding, vomiting, abdominal pain and rash were strongly associated with DSS (Table 2).
Table 1

Dengue serology of DF, DHF and DSS cases

Test

DF (n 435)

DHF (n 95)

DSS (n 26)

IgG

48

22

2

IgM

85

40

4

IgG + M

302

33

20

Table 2

Pattern of clinical presentation on day 1 of dengue cases

Symptoms

DF (n = 435)

DHF (n = 95)

DSS (n = 26)

Fever

435 (100%)

93 (97%)

26 (100%)

Bleeding

64 (15%)

56 (59%)

**18 (72%)

Headache

326 (75%)

24 (25%)

**24 (92%)

Vomit

323 (74%)

33 (35%)

**25 (96%)

Abdominal pain

310 (71%)

35 (36%)

**25 (96%)

Rash

127 (29%)

24 (25%)

**15 (58%)

(**p < 0.05).

Five days laboratory findings showed that HCT increased at 3rd day in DF cases and then returned to normal however this was constant in DHF (Figure 1). Thrombocytopenia (platelets < 100,000) was observed in 515 (93%) however 29 (5%) cases suffered from severe thrombocytopenia (platelets <10,000). ALT and AST were also de-ranged but there was no significant difference between DF and DHF (Figure 2). Records showed that platelets were transfused in 260 patients (192 DF, 48 DHF and 20 DSS) in which 19 cases had severe thrombocytopenia while in 173 cases, the count ranging from 11,000 to 40,000. About 68 (12%) patients received platelets transfusion even their counts was >40,000. The whole blood was given to 7 patients (4 DF and 3 DHF). In the treatment chart, all patients were treated in same fashion without any discrimination whether one had any other illness or not. The case record analysis showed that about 40 cases died in these hospitals. Among them 17 died of DSS, 13 from DF, 10 from DHF.
Figure 1

Pattern of Hematocrit (HCT) in DF and DHF cases. A rise in HCT was seen at 3rd week in DF patients which turned to normal. However there was a consistent pattern of HCT in DHF patients. The data of DSS could not be compared as majority of them died and 05 records was not available.

Figure 2

Five days pattern of ALT (A) and AST (B) in DF and DHF cases. The level of liver enzyme (ALT and AST) was deranged in DF and DHF cases. There was difference in level of ALT of DF cases from DHF at 3rd day of disease but this was not significant.

Verbal autopsy from relatives of 48 deceased was done. The average age of deceased was 43 years and 22 were unmarried. Of the 48 diseased cases, 29 (60%) were suffering from co-morbidities along with dengue infection. About 20 deceased patients had hypertension either alone or along with any other illness and majority of them suffered from DSS. Similarly diabetes and hepatitis B or C was also another major risk of developing DSS.

The clinical signs and symptoms reported by deceased attendants were: fever experienced by all patients followed by chill and vigour in 36, headache and breathlessness in 35, abdominal pain in 33, mental confusion in 35 and unconsciousness in 34 cases. Similarly chest pain was complained by 32 patients and this was sudden in onset in 12 and gradual in 9 while 11 had severe chest pain. Bleeding from nose, mouth and anus was reported before death in 30 (63%) cases. Key warning signs were severe and persistent vomiting and diarrhea about 4 days before death.

Discussion

The present study about verbal autopsy from relatives of deceased dengue patients showed that 58% were suffering from co-morbidities. Pakistan experienced a large dengue epidemic in Lahore in 2011 resulting in thousands of deaths. Unfortunately this was sudden and health departments were not well prepared and thus there was emphasis on case management without following any local guidelines, especially for treating those with co-morbidities. There was no systematic recording, reporting and management of co-morbidities in dengue patients thus adding to the mortality rate. Several studies have reported a strong association of co-morbidities with increased complications and deaths in dengue patients [7, 1618].

Male preponderance in present study was similar to that reported in other studies [6, 14, 18, 19]. Similarly, fever, headache, bleeding, abdominal pain and rash were common symptoms as seen previously [16, 17]. Studies also show a tendency towards higher age for the deceased patients. Our study confirmed this as 62% were more than 40 years [19, 20] in comparison with two studies which report mean age less than 40 years [15, 21]. In about 12% cases, platelets were transfused while their counts were >40,000. Irrational platelets transfusion in dengue patients has been already reported from Pakistan [22] as well as other countries [23, 24].

The patients who had previous history of any illness are more prone to develop complications. In the present study, any deceased who had hypertension either alone or along with any other illness and diabetes suffered from DSS. A study from Taiwan reported that hypertension and diabetes were risk factors for dengue hemorrhagic fever and dengue shock syndrome [25]. The warning signs in this study were severe and persistent vomiting and diarrhea which are similar to previous reports [6] in the deceased patients; fever followed by breathlessness, chills/rigor, abdominal pain, headache, stiff neck, mental confusion, unconsciousness and bleeding from mouth, nose and anus were consistent to previous reports [17, 6, 26, 27].

There were few potential limitations in the study. Firstly, this was a retrospective analysis of available records, therefore many important information were incomplete. Secondly, data of verbal autopsies was based on the memory of deceased attendants so they might have not recalled properly.

Conclusions

In conclusion, majority of deaths in 2011 epidemics might have been averted with better management of cases especially of those having co-morbidities.

Future strategies

This is recommended that efforts should be done to formulate strategies for disease management especially for screening the co-morbidities and capacity building of physicians in both public and private sector hospitals to cope with such epidemics in future and to avert deaths.

Declarations

Acknowledgements

We are thankful to Dr. Huma Qureshi, and Dr. Arif Munir, for their guidance, support and valuable comments during the analysis and their help in finalizing this report as well as Yusra Hassan Siddique for copy editing of Manuscript. We are also thankful to Mr. Saeed Ahmad Shahid (for data entry), Mr. Hafiz Saqib, Mr. Junaid Raza and other PMRC staff of Centers for their help and co-operation. The financial means for this study was provided by PMRC.

Authors’ Affiliations

(1)
Pakistan Medical Research Council (PMRC), Head Office
(2)
Pakistan Medical Research Council (PMRC) Research Centre, Fatima Jinnah Medical College
(3)
Pakistan Medical Research Council (PMRC) Research Centre, King Edward Medical University

References

  1. Mairuhu ATA, Wagenaar J, Brandjes DPM, van Gorp ECM: Dengue: an arthropod-borne disease of global importance. Eur J Clin Microbiol Infect Dis. 2004, 23: 425-433. 10.1007/s10096-004-1145-1.PubMedView ArticleGoogle Scholar
  2. Raheel U, Faheem M, Riaz MN, Kanwal N, Javed F, Zaidi N, Qadri I: Dengue fever in the Indian subcontinent: an overview. J Infect Dev Ctries. 2011, 5 (4): 239-247.PubMedGoogle Scholar
  3. Halstead SB: Dengue. Lancet. 2007, 370 (9599): 1644-1652. 10.1016/S0140-6736(07)61687-0.PubMedView ArticleGoogle Scholar
  4. Heaton NS, Randall G: Dengue Virus and Autophagy. Viruses. 2011, 3 (8): 1332-1341.PubMedPubMed CentralView ArticleGoogle Scholar
  5. Dengue and severe dengue: WHO website http://www.who.int/mediacentre/factsheets/fs117/en/ [cited on 05-01-2013]
  6. Hammond SN, Balmaseda A, Pérez L, Tellez Y, Saborío SI, Mercado JC, Videa E, Rodriguez Y, Pérez MA, Cuadra R, Solano S, Rocha J, Idiaquez W, Gonzalez A, Harris E: Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am J Trop Med Hyg. 2005, 73 (6): 1063-1070.PubMedGoogle Scholar
  7. Leo YS, Thein TL, Fisher DA, Low JG, Oh HM, Narayanan RL, Gan VC, Lee VJ, Lye DC: Confirmed adult dengue deaths in Singapore: 5-year multi-center retrospective study. BMC Infect Dis. 2011, 11: 123-10.1186/1471-2334-11-123.PubMedPubMed CentralView ArticleGoogle Scholar
  8. Figueiredo MA, Rodrigues LC, Barreto ML, Lima JW, Costa MC, Morato V, Blanton R, Vasconcelos PF, Nunes MR, Teixeira MG: Allergies and Diabetes as Risk Factors for Dengue Hemorrhagic Fever: Results of a Case Control Study. PLoS Negl Trop Dis. 2010, 4 (6): e699-10.1371/journal.pntd.0000699.PubMedPubMed CentralView ArticleGoogle Scholar
  9. Trung DT, le Thao TT, Hien TT, Hung NT, Vinh NN, Hien PT, Chinh NT, Simmons C, Wills B: Liver Involvement Associated with Dengue Infection in Adults in Vietnam. Am J Trop Med Hyg. 2010, 83 (4): 774-780. 10.4269/ajtmh.2010.10-0090.PubMedPubMed CentralView ArticleGoogle Scholar
  10. Parkash O, Almas A, Jafri SM, Hamid S, Akhtar J, Alishah H: Severity of acute hepatitis and its outcome in patients with dengue fever in a tertiary care hospital Karachi, Pakistan (South Asia). BMC Gastroenterol. 2010, 10: 43-10.1186/1471-230X-10-43.PubMedPubMed CentralView ArticleGoogle Scholar
  11. Bzeizi KI, Benmousa A, Sanai FM: Coincidence of acute brucella hepatitis and dengue fever or serologic cross-reactivity?. Saudi J Gastroenterol. 2010, 16 (4): 299-301. 10.4103/1319-3767.70621.PubMedPubMed CentralView ArticleGoogle Scholar
  12. Mpimbaza A, Filler S, Katureebe A, Kinara SO, Nzabandora E, Quick L, Ratcliffe A, Wabwire-Mangen F, Chandramohan D, Staedke SG: Validity of verbal autopsy procedures for determining malaria deaths in different epidemiological settings in Uganda. PLoS One. 2011, 6 (10): e26892-10.1371/journal.pone.0026892.PubMedPubMed CentralView ArticleGoogle Scholar
  13. Andraghetti R, Bausch D, Formenty P, Lamunu M, Leitmeyer K, Mardel S: Investigating causes of death during an outbreak of Ebola virus haemorrhagic fever: draft verbal autopsy instrument. 2003, Geneva: World Health OrganizationGoogle Scholar
  14. Palanivel C, Yadav K, Gupta V, Rai SK, Misra P, Krishnan A: Causes of death in rural adult population of North India (2002-2007), using verbal autopsy tool. Indian J Public Health. 2013, 57 (2): 78-83. 10.4103/0019-557X.114988.PubMedView ArticleGoogle Scholar
  15. Akgün S, Colak M, Bakar C: Identifying and verifying causes of death in Turkey: National verbal autopsy survey. Public Health. 2012, 126 (2): 150-158. 10.1016/j.puhe.2011.09.031.PubMedView ArticleGoogle Scholar
  16. Moraes GH, de Fátima DE, Duarte EC: Determinants of mortality from severe dengue in Brazil: a population-based case-control study. Am J Trop Med Hyg. 2013, 88 (4): 670-676. 10.4269/ajtmh.11-0774.PubMedView ArticleGoogle Scholar
  17. Lahiri M, Fisher D, Tambyah PA: Dengue mortality: reassessing the risks in transition countries. Trans R Soc Trop Med Hyg. 2008, 102 (10): 1011-1016. 10.1016/j.trstmh.2008.06.005.PubMedView ArticleGoogle Scholar
  18. Tomashek KM, Gregory CJ, Rivera Sánchez A, Bartek MA, GarciaRivera EJ, Hunsperger E, Muñoz-Jordán JL, Sun W: Dengue Deaths in Puerto Rico: Lessons Learned from the 2007 Epidemic. PLoS Negl Trop Dis. 2012, 6 (4): e1614-10.1371/journal.pntd.0001614.PubMedPubMed CentralView ArticleGoogle Scholar
  19. Fajardo-Dolci G, Meljem-Moctezuma J, Vicente-González E, Venegas-Páez FV, Villalba-Espinoza I, Pérez-Cardoso AL, Barrón-Saldaña DA, Barragán-Ramírez C, Novoa-Boldo A, Aguirre-Güemez AV, Mendoza-Larios LA, Mazón-González B, Montesinos-Gómez G, López-González R, Aguirre-Gas HG: Analysis of dengue fever deaths in Mexico: 2009. Rev Med Inst Mex Seguro Soc. 2012, 50 (6): 589-598.PubMedGoogle Scholar
  20. Juneja D, Nasa P, Singh O, Javeri Y, Uniyal B, Dang R: Clinical profile, intensive care unit course, and outcome of patients admitted in intensive care unit with dengue. J Crit Care. 2011, 26 (5): 449-452. 10.1016/j.jcrc.2011.05.007.PubMedView ArticleGoogle Scholar
  21. Mahajan SL, Sohal SP, Devgun P, Mahajan S, Mahajan S, Padda P: A study of frequency distribution and some epidemiological features of reported cases and deaths of dengue in Ludhiana district during the year 2008. J Commun Dis. 2010, 42 (2): 139-146.PubMedGoogle Scholar
  22. Munir MA: Retrospective study of dengue fever patients admitted in tertiary care hospitals in Pakistan.http://www.pmrc.org.pk/Dengue_Report_%202011.pdf,
  23. Pallavi P, Ganesh CK, Jayashree K, Manjunath GV: Unfurling the rationale use of platelet transfusion in dengue Fever. Indian J Hematol Blood Transfus. 2011, 27 (2): 70-74. 10.1007/s12288-011-0059-1.PubMedPubMed CentralView ArticleGoogle Scholar
  24. Makroo RN, Raina V, Kumar P, Kanth RK: Role of platelet transfusion in the management of dengue patients in a tertiary care hospital. Asian J Transfus Sci. 2007, 1 (1): 4-7. 10.4103/0973-6247.28065.PubMedPubMed CentralView ArticleGoogle Scholar
  25. Pang J, Salim A, Lee VJ, Hibberd ML, Chia KS, Leo YS, Lye DC: Diabetes with Hypertension as Risk Factors for Adult Dengue Hemorrhagic Fever in a Predominantly Dengue Serotype 2 Epidemic: A Case Control Study. PLoS Negl Trop Dis. 2012, 6 (5): e1641-10.1371/journal.pntd.0001641.PubMedPubMed CentralView ArticleGoogle Scholar
  26. Guzmán MG, Alvarez M, Rodríguez R, Rosario D, Vázquez S, Vald sL, Cabrera MV, Kourí G: Fatal dengue hemorrhagic fever in Cuba, 1997. Int J Infect Dis. 1999, 3 (3): 130-135. 10.1016/S1201-9712(99)90033-4.PubMedView ArticleGoogle Scholar
  27. Anders KL, Nguyet NM, Chau NV, Hung NT, Thuy TT, le Lien B, Farrar J, Wills B, Hien TT, Simmons CP: Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam. Am J Trop Med Hyg. 2011, 84 (1): 127-134. 10.4269/ajtmh.2011.10-0476.PubMedPubMed CentralView ArticleGoogle Scholar

Copyright

© Saqib et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

Advertisement